immunity News and Research

RSS

Study reveals mechanisms behind antibiotic-related immune disruptions in infants

In 2017, scientists at Cincinnati Children's revealed that using antibiotics to protect newborns from dangerous infections often comes with a long-term consequence-a permanently underdeveloped immune system that can make children prone to poor outcomes from future lung infections.

9 Jun 2025

‘We dissent’: NIH workers protest Trump policies that ‘harm the health of Americans’

Hundreds of workers at the National Institutes of Health on Monday openly protested the Trump administration’s cuts to the agency and consequences for human lives, writing in a sharply worded letter that its actions are causing "a dramatic reduction in life-saving research."

9 Jun 2025

Scientists unlock potential of cytokine adjuvants in mRNA vaccines

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for more tools for their arsenal.

6 Jun 2025

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance

The Global Virus Network (GVN) is closely monitoring the emergence of a newly identified SARS-CoV-2 variant, NB.1.8.1, a sublineage of the Omicron family. This variant was first identified in January 2025 and has rapidly spread across Asia and into other regions, including parts of the United States.

6 Jun 2025

Mitochondrial DNA variant predicts resistance to melanoma immunotherapy

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do not respond to the latest cancer treatments.

6 Jun 2025

Maternal exposure to metals rewires infants’ gut and resistance genes

Prenatal exposure to trace elements like selenium, copper, and arsenic can significantly alter the infant gut microbiome, metabolism, and antibiotic resistance gene patterns. These changes appear as early as three months and evolve during the first year of life.

5 Jun 2025

Genetic mutation identified as key factor in immunotherapy resistance for melanoma

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of those who did not respond to the latest cancer treatments, known as immune checkpoint inhibitors.

5 Jun 2025

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

Efforts to reduce child mortality in Africa via mass treatment with the antibiotic azithromycin (AZM) may lead to increased drug resistance in bacteria that frequently cause pneumonia and meningitis, highlighting the need for careful monitoring, finds a new study led by UCL.

4 Jun 2025

Navigating the dual role of B cells in tumor immunity

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

3 Jun 2025

Individual immune variation shapes the evolution of influenza strains

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.

3 Jun 2025

PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review

Physician-scientists at Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have successfully completed initial safety evaluations in 30 adult Burkinabés as the first phase of a clinical trial of Sanaria PfSPZ-LARC2 Vaccine, which is designed to prevent infection with Plasmodium falciparum malaria.

3 Jun 2025

Myeloid cells shape tumor microenvironments and influence cancer progression

Recent advances in cancer research have underscored the critical role of myeloid cells in shaping tumor microenvironments (TME), influencing tumor progression, immune evasion, and therapeutic resistance.

3 Jun 2025

Study: New mRNA vaccine is more scalable and adaptable to continuously evolving viruses

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University.

3 Jun 2025

Study uncovers how HSV-1 disables the brain's antiviral defense

Infections caused by herpes simplex virus type 1 (HSV-1) can lead to HSV-1 encephalitis-a rare but deadly condition that inflames the brain.

3 Jun 2025

MMR vaccination rates decline in most U.S. counties since the pandemic

A new county-level dataset from Johns Hopkins University researchers reveals a national decline in the measles-mumps-rubella (MMR) vaccination rate among U.S. children since the start of the COVID-19 pandemic.

2 Jun 2025

Engineered viruses and gene therapy halt tumor growth and extend survival in mice

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor destruction in aggressive cancer models.

2 Jun 2025

New combination treatment offers hope for immune checkpoint blockade resistant skin cancers

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment.

2 Jun 2025

RFK Jr. says healthy pregnant women don’t need covid boosters. What the science says.

You're pregnant, healthy, and hearing mixed messages: Health and Human Services Secretary Robert F. Kennedy Jr., who is not a scientist or doctor, says you don't need the covid vaccine, but experts at the Centers for Disease Control and Protection still put you in a high-risk group of people who ought to receive boosters.

2 Jun 2025

Digital baby formula campaigns undermine breastfeeding and put child health at risk

A global resolution on digital marketing of breast milk substitutes must be rigorously enforced, writes Afshan Khan, Assistant Secretary-General of the United Nations and coordinator of the Scaling Up Nutrition (SUN) Movement.

1 Jun 2025

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating that the combination of avelumab and cetuximab improved progression-free survival (PFS) compared to avelumab alone in patients with advanced cutaneous squamous cell carcinoma (cSCC).

1 Jun 2025

immunity News and Research

Study reveals mechanisms behind antibiotic-related immune disruptions in infants

‘We dissent’: NIH workers protest Trump policies that ‘harm the health of Americans’

Scientists unlock potential of cytokine adjuvants in mRNA vaccines

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance

Mitochondrial DNA variant predicts resistance to melanoma immunotherapy

Maternal exposure to metals rewires infants’ gut and resistance genes

Genetic mutation identified as key factor in immunotherapy resistance for melanoma

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

Navigating the dual role of B cells in tumor immunity

Individual immune variation shapes the evolution of influenza strains

PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review

Myeloid cells shape tumor microenvironments and influence cancer progression

Study: New mRNA vaccine is more scalable and adaptable to continuously evolving viruses

Study uncovers how HSV-1 disables the brain's antiviral defense

MMR vaccination rates decline in most U.S. counties since the pandemic

Engineered viruses and gene therapy halt tumor growth and extend survival in mice

New combination treatment offers hope for immune checkpoint blockade resistant skin cancers

RFK Jr. says healthy pregnant women don’t need covid boosters. What the science says.

Digital baby formula campaigns undermine breastfeeding and put child health at risk

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News